Evidence map›Paper›PMID 42032425›Full record

ArticleDiscover oncology2026

Uterine carcinosarcoma with concurrent right nephrolithiasis case report.

Hede Shen, Li He, Xia Ye, Fei Shi, Hexi Shen

Abstract read
In one paragraph

Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hede ShenDepartment of Pathology, Zhejiang Provincial People's Hospital Bijie Hospital, Bijie, Guizhou, China.
Li HeDepartment of Pathology, Zhejiang Provincial People's Hospital Bijie Hospital, Bijie, Guizhou, China.
Xia YeDepartment of Pathology, Zhejiang Provincial People's Hospital Bijie Hospital, Bijie, Guizhou, China.
Fei ShiDepartment of Pathology, Zhejiang Provincial People's Hospital Bijie Hospital, Bijie, Guizhou, China.
Hexi ShenSchool of Municipal and Environmental Engineering, Shandong Jianzhu University, Jinan, China. shenhexi19@sdjzu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimUterine carcinosarcoma (UCS) is a rare and highly invasive gynecological malignancy with insidious clinical manifestations, particularly in underdeveloped regions where patients often neglect routine health screenings, missing the optimal opportunity for early intervention. This report aims to enhance the understanding of UCS by presenting the diagnosis and treatment process of a case. CASE PRESENTATION: A 57-year-old woman with right lumbar pain underwent B-ultrasound at a local health center, which identified a right renal stone. During the abdominal examination, a palpable mass was noted in the right lower abdomen. An magnetic resonance imaging (MRI) performed at our hospital revealed a large, irregular mass in the pelvic cavity, showing mixed abnormal signal intensity, measuring approximately 100 mm × 50 mm × 40 mm (left-right × anterior-posterior × craniocaudal diameter). Histopathological analysis of the resected tissue confirmed uterine carcinosarcoma.

conclusionUCS is a rare and highly aggressive malignancy. Owing to its subtle early clinical manifestations, it is frequently diagnosed at intermediate or advanced stages. Early detection and timely treatment are critical for improving patient outcomes. Raising awareness of the importance of regular health check-ups among postmenopausal women is essential.

Indexed as

Clinical and pathological featuresDiagnosis and treatmentImmunohistochemistryMolecular pathologyUCS

Identifiers

PMID42032425
PMCPMC13247097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.